SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) Gross margin 2024–2025
SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) gross margin by fiscal year — reported gross profit divided by reported revenue.
-202.3%FY2025 · since FY2024: -88.1% → -202.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -202.3% | -114.1 pp |
| FY2024 | -88.1% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More SCNI financial trends
SCNI RevenueSCNI Net incomeSCNI Net marginSCNI Gross profitSCNI Operating incomeSCNI Operating marginSCNI Operating cash flowSCNI Free cash flowSCNI Capital expendituresSCNI Return on equitySCNI Stock buybacksSCNI Dividends paidSCNI Total assetsSCNI Total liabilitiesSCNI Shareholders’ equitySCNI overview →